Bank of New York Mellon »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.4M 122k 19.78
2024-09-30 $2.3M 92k 24.99
2024-06-30 $2.1M 115k 18.67

More positions owned by Bank of New York Mellon

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl C Cap (GOOG)
Ishares Core S&p 500 Etf Core (IVV)
Broadcom (AVGO)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Mastercard Inc - A Cl A (MA)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)

View all positions for Bank of New York Mellon

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

BlackRock
Braidwell
Vanguard Group
Baker Bros. Advisors
Rubric Capital Management
Fairmount Funds Management
Hillhouse Capital Advisors
Morgan Stanley
Pictet Asset Management Holding SA
Nuveen Asset Management
Millennium Management
Dimensional Fund Advisors
Parkman Healthcare Partners
State Street Corporation
FMR

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A